Similarly, conventional tumor diagnostic markers such as carcinoembryonic antigen (CEA), CA 15-3, and CA 125 prove impractical in detecting early phase breast cancer due to their low sensitivity. This evidence concerns the gene CEACAM5 and neoplasm.